These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31487633)

  • 1. The apelinergic-axis in human preeclamptic pregnancies: A systematic review.
    Georgiadou D; Afink GB; van Dijk M
    Pregnancy Hypertens; 2019 Jul; 17():148-157. PubMed ID: 31487633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elabela and Apelin actions in healthy and pathological pregnancies.
    Eberlé D; Marousez L; Hanssens S; Knauf C; Breton C; Deruelle P; Lesage J
    Cytokine Growth Factor Rev; 2019 Apr; 46():45-53. PubMed ID: 30910349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Apelinergic System in Pregnancy.
    Pécheux O; Correia-Branco A; Cohen M; Martinez de Tejada B
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biological function of ELABELA and APJ signaling in the cardiovascular system and pre-eclampsia.
    Liu Y; Wang L; Shi H
    Hypertens Res; 2019 Jul; 42(7):928-934. PubMed ID: 30626933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apelin, APJ, and ELABELA: Role in Placental Function, Pregnancy, and Foetal Development-An Overview.
    Dawid M; Mlyczyńska E; Jurek M; Respekta N; Pich K; Kurowska P; Gieras W; Milewicz T; Kotula-Balak M; Rak A
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ELABELA, as a potential diagnostic biomarker of preeclampsia, regulates abnormally shallow placentation via APJ.
    Zhou L; Sun H; Cheng R; Fan X; Lai S; Deng C
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E773-E781. PubMed ID: 30860880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ELABELA/APELA Levels Are Not Decreased in the Maternal Circulation or Placenta among Women with Preeclampsia.
    Pritchard N; Kaitu'u-Lino TJ; Gong S; Dopierala J; Smith GCS; Charnock-Jones DS; Tong S
    Am J Pathol; 2018 Aug; 188(8):1749-1753. PubMed ID: 29803833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of apelin and APJ receptor in normal and preeclampsia-complicated placentas.
    Cobellis L; De Falco M; Mastrogiacomo A; Giraldi D; Dattilo D; Scaffa C; Colacurci N; De Luca A
    Histol Histopathol; 2007 Jan; 22(1):1-8. PubMed ID: 17128405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Apelinergic System: Apelin, ELABELA, and APJ Action on Cell Apoptosis: Anti-Apoptotic or Pro-Apoptotic Effect?
    Respekta N; Pich K; Dawid M; Mlyczyńska E; Kurowska P; Rak A
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of apelin and Elabela in cardiovascular disease.
    Gao S; Chen H
    Biomed Pharmacother; 2023 Oct; 166():115268. PubMed ID: 37562237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology.
    Kuba K; Sato T; Imai Y; Yamaguchi T
    Peptides; 2019 Jan; 111():62-70. PubMed ID: 29684595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological functions of Elabela, a novel endogenous ligand of APJ receptor.
    Xu J; Chen L; Jiang Z; Li L
    J Cell Physiol; 2018 Sep; 233(9):6472-6482. PubMed ID: 29350399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of role of vascular endothelial growth factor, Annexin A5 and Apelin by immunohistochemistry method in placenta of preeclampsia patients.
    Colcimen N; Bulut G; Ergul Erkec O; Ragbetli MC
    Cell Mol Biol (Noisy-le-grand); 2017 Nov; 63(11):42-45. PubMed ID: 29208172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the elabela/apelin-apelin receptor axis as a novel therapeutic approach for hypertension.
    Song J; Tang J; Zhang Z; Liu Y; Zhong J
    Chin Med J (Engl); 2022 May; 135(9):1019-1026. PubMed ID: 34608073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apelin/APJ system protects placental trophoblasts from hypoxia-induced oxidative stress through activating PI3K/Akt signaling pathway in preeclampsia.
    Ye L; Huang Y; Liu X; Zhang X; Cao Y; Kong X; Yuan X; Xu J; Zhu H
    Free Radic Biol Med; 2023 Nov; 208():759-770. PubMed ID: 37774802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice.
    Ho L; van Dijk M; Chye STJ; Messerschmidt DM; Chng SC; Ong S; Yi LK; Boussata S; Goh GH; Afink GB; Lim CY; Dunn NR; Solter D; Knowles BB; Reversade B
    Science; 2017 Aug; 357(6352):707-713. PubMed ID: 28663440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elabela-apelin-12, 17, 36/APJ system promotes platelet aggregation and thrombosis via activating the PANX1-P2X7 signaling pathway.
    Chen Z; Luo X; Liu M; Jiang J; Li Y; Huang Z; Wang L; Cao J; He L; Huang S; Hu H; Li L; Chen L
    J Cell Biochem; 2023 Apr; 124(4):586-605. PubMed ID: 36855998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal obesity reduces apelin level in cord blood without altering the placental apelin/elabela-APJ system.
    Hanssens S; Marousez L; Pécheux O; Besengez C; Storme L; Deruelle P; Eberlé D; Lesage J
    Placenta; 2022 Oct; 128():112-115. PubMed ID: 36152345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elabela/Toddler and apelin bind differently to the apelin receptor.
    Couvineau P; Llorens-Cortes C; Iturrioz X
    FASEB J; 2020 Jun; 34(6):7989-8000. PubMed ID: 32301550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.